| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Astria Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 23 Jan 2026 | Direct | ||
| Orchard Therapeutics plc | Director | Ordinary Shares | 0 | $0.4591 | 24 Jan 2024 | Direct | |
| Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | 24 Jan 2024 | Direct |